AbML (Antibody Markup Language) and abYdraw are designed for describing, drawing and rendering complex antibody-based drugs.
AbML (Antibody Markup Language) is our new language to describe the format of antibody-based drugs, particularly multi-specific constructs.
abYdraw is a Python program to render AbML strings and to draw and edit domain structures of antibody-based drugs and to generate the associated AbML.
abYdraw renders AbML and allows the domain structure of a complex antibody-based drug to be drawn and saved as an image or as AbML.
Documentation for the abYdraw graphical interface.
AbML is designed as a simple, but expressive language for describing complex antibody-based drug format.
abYdraw source code is available on GitHub.
AbML was developed between 2020 and 2022 by Maham Ahmad (a Birkbeck Bioinformatics MSc student), James Sweet-Jones and Andrew Martin.
abYdraw was developed between 2021 and 2022 by James Sweet-Jones and Andrew Martin. JS-J is funded by a BBSRC LIDo stdentship.